EUVIMEDEUVIMED entdecken
Crossref

AKR1B1 Inhibits Ferroptosis and Promotes Gastric Cancer Progression via Interacting With STAT3 to Activate SLC7A11

Kaiyan Yang, Xin Zhang, Fei Long, Jing Dai

Cell Biology International · 2025

DOI: 10.1002/cbin.12275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, 2025. Verfasst von Kaiyan Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Third XiangYa Hospital of Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Ferroptosis, Stomach Neoplasms, STAT3 Transcription Factor, Amino Acid Transport System y+. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is a frequently diagnosed malignant tumor in clinical settings; however, the mechanisms underlying its tumorigenesis remain inadequately understood. In this study, we identified significantly elevated expression levels of AKR1B1 in GC tissues through quantitative polymerase chain reaction (qPCR) and western blotting assays. Furthermore, a negative correlation was established between patient survival probability and AKR1B1 expression levels. Functionally, our experiments, including colony formation, transwell migration, and xenograft assays, demonstrated that the depletion of AKR1B1 inhibited the proliferation and progression of GC cells both in vivo and in vitro. Additionally, the assessment of reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), and mitochondrial morphology confirmed that AKR1B1 depletion induces ferroptosis. Mechanistically, we found that AKR1B1 interacts with STAT3, which subsequently activates SLC7A11. Notably, the ferroptosis induced by AKR1B1 depletion could be reversed by the overexpression of SLC7A11, thereby substantiating these interactions. In conclusion, our findings identify AKR1B1 as a novel oncogene in GC and elucidate the mechanism involving the AKR1B1‐STAT3‐SLC7A11 pathway and ferroptosis, providing new insights for potential therapeutic strategies in the treatment of GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisStomach NeoplasmsSTAT3 Transcription FactorAmino Acid Transport System y+Aldehyde ReductaseHumansAnimalsCell Line, TumorMiceReactive Oxygen SpeciesCell ProliferationMice, NudeMice, Inbred BALB CDisease ProgressionGene Expression Regulation, NeoplasticMaleFemaleCell Movement

Stichwörter der Autor:innen

AKR1B1SLC7A11ferroptosisgastric cancer

Substanzen

STAT3 Transcription FactorSTAT3 protein, humanSLC7A11 protein, humanAmino Acid Transport System y+AKR1B1 protein, humanReactive Oxygen SpeciesAldehyde Reductase

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Third XiangYa Hospital of Central South University, Changsha, Hunan, China.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Yang, K., Zhang, X., Long, F., & Dai, J. (2025). AKR1B1 Inhibits Ferroptosis and Promotes Gastric Cancer Progression via Interacting With STAT3 to Activate SLC7A11. Cell Biology International. https://doi.org/10.1002/cbin.12275

Vancouver

Yang K, Zhang X, Long F, Dai J. AKR1B1 Inhibits Ferroptosis and Promotes Gastric Cancer Progression via Interacting With STAT3 to Activate SLC7A11. Cell Biology International. 2025. doi:10.1002/cbin.12275

BibTeX
@article{Yang2025,
  author = {Yang, Kaiyan and Zhang, Xin and Long, Fei and Dai, Jing},
  title = {AKR1B1 Inhibits Ferroptosis and Promotes Gastric Cancer Progression via Interacting With STAT3 to Activate SLC7A11},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.12275}
}
Kostenlos starten →